Development and clinical validation of HPLC method for precise quantification of paclitaxel in plasma from breast cancer patients
Najia Rahim, Sadia Shakeel, Maryum Nouman, Sadia Asim, Javeria Chaudhry, Zulqarnain Hassan · 2026
Read Development and clinical validation of HPLC method for precise quantification of paclitaxel in plasma from breast cancer patients by Najia Rahim, Sadia Shakeel, Maryum Nouman, Sadia Asim, Javeria Chaudhry, Zulqarnain Hassan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0358891.txt.
Description
Najia Rahim, Sadia Shakeel, Maryum Nouman, Sadia Asim, Javeria Chaudhry, and Zulqarnain Hassan wrote this 2026 PLOS ONE research article. It reports the development and clinical validation of an HPLC method, a laboratory technique for measuring substances in liquid samples. The substance measured is paclitaxel, a chemotherapy drug, in blood plasma.
The samples come from patients with breast cancer, where knowing the exact drug level in blood can guide dosing. Validation means proving the method measures precisely and reliably in real clinical samples. Hospital laboratories and cancer pharmacology teams are the readers who need a trustworthy paclitaxel assay of this kind.
Catalog record
| CREATOR | Najia Rahim, Sadia Shakeel, Maryum Nouman, Sadia Asim, Javeria Chaudhry, Zulqarnain Hassan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32811 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |